The role of gastrin in colorectal carcinogenesis

Surgeon

Volumn 2, Issue 5, 2004, Pages 251-257

  Takhar, Arjun S ^a   Eremin, O ^a   Watson, S A ^a  

^a UNIVERSITY OF NOTTINGHAM   (United Kingdom)

Author keywords

Adenoma; APC; Carcinoma sequence; CCK 2 receptor; Colon; Gastrin

Indexed keywords

APC PROTEIN; CHOLECYSTOKININ B RECEPTOR; CHOLECYSTOKININ B RECEPTOR ANTAGONIST; EPIDERMAL GROWTH FACTOR RECEPTOR; G 17DT; GASTRIN; GASTRIN ANTAGONIST; GASTRIN RECEPTOR; GASTROZOLE; K RAS PROTEIN; MATRIX METALLOPROTEINASE; PEPTIDE HORMONE; PROTEIN P53; SMALL INTERFERING RNA; TUMOR ANTIGEN; UNCLASSIFIED DRUG;

CANCER STAGING; CARCINOGENESIS; CLINICAL TRIAL; COLON ADENOCARCINOMA; COLON MUCOSA; COLORECTAL CANCER; DNA FLANKING REGION; DRUG TARGETING; EPITHELIUM CELL; GENE ACTIVATION; GENE EXPRESSION; GENE MUTATION; GENE SEQUENCE; HUMAN; MOUSE; NONHUMAN; PANCREAS CANCER; RECEPTOR GENE; REVIEW; SEQUENCE HOMOLOGY; STOMACH ACID SECRETION; STOMACH EPITHELIUM; TRANSCRIPTION INITIATION;

EID: 6444221158     PISSN: 1479666X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1479-666X(04)80093-3     Document Type: Review

References (58)

1. Cancer Facts and Figures-2002. American Cancer Society 2002.
2. Quinn M, Babb P, Brock A, Kirby L, Jones J. Cancer Trends in England and Wales 1950-1999. Office of National Statistics 2001.
3. Morson BC. The pathogenesis of colorectal cancer. Introduction. Major Probl Pathol 1978; 10: 1-13.
4. Muto T, Bussey HJ, Morson BC. The evolution of cancer of the colon and rectum. Cancer 1975; 36(6):2251-70.
5. Fenoglio CM, Lane N. The anatomical precursor of colorectal carcinoma. Cancer 1974; 34 (3):suppl:819-23.
6. Jen J, Powell SM, Papadopoulos N, Smith KJ, Hamilton SR, Vogelstein B, Kinzler KW. Molecular determinants of dysplasia in colorectal lesions. Cancer Res 1994; 54(21):5523-26.
7. Winawer SJ, Zauber AG, Ho MN, O'Brien MJ, Gottlieb LS, Sternberg SS, Stewart ET, Bond JH, Schapiro M, Panish JF et al. The National Polyp Study. Eur J Cancer Prev 1993; 2 Suppl 2:83-87.
8. Winawer SJ, Stewart ET, Zauber AG, Bond JH, Ansel H, Waye JD, Hall D, Hamlin JA, Schapiro M, O'Brien MJ, Sternberg SS, Gottlieb LS. A comparison of colonoscopy and double-contrast barium enema for surveillance after polypectomy. National Polyp Study Work Group. N Engl J Med 2000; 342(24):1766-72.
9. Muller AD, Sonnenberg A. Protection by endoscopy against death from colorectal cancer. A case-control study among veterans. Arch Intern Med 1995; 155(16): 1741-48.
10. Fearon ER, Vogelstein B. A genetic model for colorectal tumorigenesis. Cell 1990; 61(5):759-67.
11. Vogelstein B, Kinzler KW. The multistep nature of cancer. Trends Genet 1993; 9(4):138-41.
12. Lengauer C, Kinzler KW, Vogelstein B. Genetic instabilities in human cancers. Nature 1998; 396(6712):643-49.
13. Kinzler KW, Vogelstein B. Landscaping the cancer terrain. Science 1998; 280(5366):1036-37.
14. Nakata H, Wang SL, Chung DC, Westwick JK, Tillotson LG. Oncogenic ras induces gastrin gene expression in colon cancer. Gastroenterology 1998; 115(5):1144-53.
15. Laghi L, Ranzani GN, Bianchi P, Mori A, Heinimann K, Orbetegli O, et al. Frameshift mutations of human gastrin receptor gene (hGARE) in gastrointestinal cancers with microsatellite instability. Lab Invest 2002; 82:265-71.
16. Jeong SY, Shin KH, Shin JH, Ku JL, Shin YK, Park SY, et al. Microsatellite instability and mutations in DNA mismatch repair genes in sporadic colorectal cancers. Dis Colon Rectum 2003; 46 8):1069-77.
17. Rodrigues NR, Rowan A, Smith ME, Kerr IB, Bodmer WF, Gannon JV, et al. p53 mutations in colorectal cancer. Proc Natl Acad Sci U S A 1990; 87(19):7555-59.
18. Watson SA, McKenzie A, Grabowska A, Grimes S, Broome P, Michaeli D. Synergistic inhibitory effects of G17DT on gastrointestinal tumour growth in combination with cytotoxic agents. J Clin Oncol 2003; 21(S):3497.
19. Merchant JL. EGF receptor activation of the human gastrin gene: a tale of two zinc finger transcription factor families. Keio J Med 2000; 49(3):106-10.
20. Chiba T, Fukui H, Kinoshita Y. Reg protein: a possible mediator of gastrin-induced mucosal cell growth. J Gastroenterol 2000; 35 Suppl 12:52-56.
21. Wroblewski LE, Pritchard DM, Carter S, Varro A. Gastrin-stimulated gastric epithelial cell invasion: the role and mechanism of increased matrix metalloproteinase 9 expression. Biochem J 2002; 365(Pt 3):873-79.
22. Kermorgant S, Lehy T. Glycine-extended gastrin promotes the invasiveness of human colon cancer cells. Biochem Biophys Res Commun 2001; 285(1):136-41.
23. Lee YM, Beinborn M, McBride EW, Lu M, Kolakowski LF, Jr., Kopin AS. The human brain cholecystokinin-B/gastrin receptor. Cloning and characterization. J Biol Chem 1993; 268(11):8164-69.
24. Singh P, Owlia A, Espeijo R, Dai B. Novel gastrin receptors mediate mitogenic effects of gastrin and processing intermediates of gastrin on Swiss 3T3 fibroblasts. Absence of detectable cholecystokinin (CCK)-A and CCK-B receptors. J Biol Chem 1995; 270 15):8429-38.
25. Malecka-Panas E, Fligiel SE, Jaszewski R, Majumdar AP. Differential responsiveness of proximal and distal colonic mucosa to gastrin. Peptides 1997; 18(4):559-65.
26. Ekundayo AA, Lee CY, Goodlad RA. Gastrin and the growth of the gastrointestinal tract. Gut 1995; 36(2):203-8.
27. Chen D, Destree M, Hakanson R, Willems G. Endogenous hypergastrinaemia does not promote growth of colonic mucosa or of a transplanted colon adenocarcinoma in rats. Eur J Gastroenterol Hepatol 1998; 10(4):293-99.
28. Wang TC, Koh TJ, Varro A, Cahill RJ, Dangler CA, Fox JG, et al. Processing and proliferative effects of human progastrin in transgenic mice. J Clin Invest 1996; 98(8): 1918-29.
29. Koh TJ, Goldenring JR, Ito S, Mashimo H, Kopin AS, Varro A, Dockray GJ, Wang TC. Gastrin deficiency results in altered gastric differentiation and decreased colonic proliferation in mice. Gastroenterology 1997; 113(3):1015-25.
30. Singh P, Velasco M, Given R, Wargovich M, Varro A, Wang TC. Mice overexpressing progastrin are predisposed for developing aberrant colonic crypt foci in response to AOM. Am J Physiol Gastrointest Liver Physiol 2000; 278(3):G390-99.
31. Aly A, Shulkes A, Baldwin GS. Short term infusion of glycine-extended gastrin(17) stimulates both proliferation and formation of aberrant crypt foci in rat colonic mucosa. Int J Cancer 2001; 94(3):307-13.
32. Koh TJ, Bulitta CJ, Fleming JV, Dockray GJ, Varro A, Wang TC. Gastrin is a target of the beta-catenin/TCF-4 growth-signaling pathway in a model of intestinal polyposis. J Clin Invest 2000; 106 4):533-39.
33. Watson SA, Michaeli D, Morris TM, McWilliams D, Smith AM. The role of gastrin in the adenoma-carcinoma sequence in the colon. Digestion 1999; 60:O-25.
34. Smith AM, Watson SA. Gastrin and gastrin receptor activation: an early event in the adenoma-carcinoma sequence. Gut 2000; 47 6):820-24.
35. Watson SA, Clarke PA, Smith AM, Varro A, Michaeli D, Grimes S, Caplin M, Hardcastle J. Expression of CCKB/gastrin receptor isoforms in gastro-intestinal tumour cells. Int J Cancer 1998; 77 4):572-77.
36. Watson SA, Smith AM. Hypergastrinemia promotes adenoma progression in the APC(Min-/+) mouse model of familial adenomatous polyposis. Cancer Res 2001; 61(2):625-31.
37. Koh TJ, Dockray GJ, Varro A, Cahill RJ, Dangler CA, Fox JG, Wang TC. Overexpression of glycine-extended gastrin in transgenic mice results in increased colonic proliferation. J Clin Invest 1999; 103(8):1119-26.
38. Hellmich MR, Rui XL, Hellmich HL, Fleming RY, Evers BM, Townsend CM, Jr. Human colorectal cancers express a constitutively active cholecystokinin-B/gastrin receptor that stimulates cell growth. J Biol Chem 2000; 275(41):32122-28.
39. Seitz JF, Giovannini M, Gauthier A. Elevated gastrin levels in patients with colorectal cancer. J Clin Gastroenterol 1989; 11(3):362.
40. Seitz JF, Giovannini M, Delpero JR, Gauthier AP. Gastrin levels and colorectal cancer. Dis Colon Rectum 1989; 32 5):449-50.
41. Seitz JF, Giovannini M, Gouvernet J, Gauthier AP. Elevated serum gastrin levels in patients with colorectal neoplasia. J Clin Gastroenterol 1991; 13(5):541-45.
42. Smith JP, Wood JG, Solomon TE. Elevated gastrin levels in patients with colon cancer or adenomatous polyps. Dig Dis Sci 1989; 34(2):171-74.
43. Thorburn CM, Friedman GD, Dickinson CJ, Vogelman JH, Orentreich N, Parsonnet J. Gastrin and colorectal cancer: a prospective study. Gastroenterology 1998; 115(2):275-80.
44. Breuer-Katschinski B, Nemes K, Marr A, Rump B, Leiendecker B, Breuer N, Goebell H. Helicobacter pylori and the risk of colonic adenomas. Colorectal Adenoma Study Group. Digestion 1999; 60 3):210-15.
45. Ciccotosto GD, McLeish A, Hardy KJ, Shulkes A. Expression, processing, and secretion of gastrin in patients with colorectal carcinoma. Gastroenterology 1995; 109(4):1142-53.
46. Siddheshwar RK, Gray JC, Kelly SB. Plasma levels of progastrin but not amidated gastrin or glycine extended gastrin are elevated in patients with colorectal carcinoma. Gut 2001; 48 1):47-52.
47. Muhammad KB, Watson, SA, Clarke P, Pritchard C, Charnley R, Manas D, Bennett M, Kelly SB. Expression of tissue progastrin, CCK-B/gastrin receptor and cell proliferation in hepatic metastases from colorectal cancer. Gastroenterology 2003; 124:M1079.
48. Heneghan MA, Hull R, Kane P, Shankley N, Kalindjian S, Tredger JM, Black JW, Harrison PM. Use of a novel CCKB/gastrin antagonist, Gastrozole (JB5008) in patients with advances pancreatic adenocarcinoma. Results of an open labelled pilot. Gastroenterology 2001; 120(S1): 3108.
49. Hoosein NM, Kiener PA, Curry RC, Rovati LC, McGilbra DK, Brattain MG. Antiproliferative effects of gastrin receptor antagonists and antibodies to gastrin on human colon carcinoma cell lines. Cancer Res 1988; 48(24 Pt 1):7179-83.
50. Smith AM, Watson SA. Gastrin and gastrin receptor activation: an early event in the adenoma-carcinoma sequence. Gut 2000; 47 6):820-24.
51. Hoosein NM, Kiener PA, Curry RC, Rovati LC, McGilbra DK, Brattain MG. Antiproliferative effects of gastrin receptor antagonists and antibodies to gastrin on human colon carcinoma cell lines. Cancer Res 1988; 48(24 Pt 1): 7179-83.
52. Smith AM, Justin T, Michaeli D, Watson SA. Phase I/II study of G17-DT, an anti-gastrin immunogen, in advanced colorectal cancer. Clin Cancer Res 2000; 6(12):4719-24.
53. Watson SA, Morris TM, McWilliams DF, Harris J, Evans S, Smith A, Clarke PA. Potential role of endocrine gastrin in the colonic adenoma carcinoma sequence. Br J Cancer 2002; 87(5):567-73.
54. Upp JR Jr, Singh P, Townsend CM Jr, Thompson JC. Clinical significance of gastrin receptors in human colon cancers. Cancer Res 1989; 49(2): 488-92.
55. Imdahl A, Mantamadiotis T, Eggstein S, Farthmann EH, Baldwin GS. Expression of gastrin, gastrin/CCK-B and gastrin/CCK-C receptors in human colorectal carcinomas. J Cancer Res Clin Oncol 1995; 121 11): 661-66.
56. Reubi JC, Schaer JC, Waser B. Cholecystokinin (CCK)-A and CCK-B/gastrin receptors in human tumors. Cancer Res 1997; 57 7): 1377-86.
57. Matsushima Y, Kinoshita Y, Nakata H, Inomoto-Naribayashi Y, Asahara M, Kawanami C et al. Gastrin receptor gene expression in several human carcinomas. Jpn J Cancer Res 1994; 85(8): 819-24.
58. Schmitz F, Otte JM, Stechele HU, Reimann B, Banasiewicz T, Folsch UR et al. CCK-B/gastrin receptors in human colorectal cancer. Eur J Clin Invest 2001; 31(9): 812-20.